Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed M Dar

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Oncology Reports|August 5, 2003
Vaccination strategies for lymphomasMohammed M Dar, Larry W Kwak
Nature Reviews. Cancer|January 26, 2007
Targeted anti-mitotic therapies: can we improve on tubulin agents?Jeffrey R Jackson, Denis R Patrick, Mohammed M Dar, et al.
Clinical Colorectal Cancer|May 26, 2011
A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumorsTrevor W Dennie, Ronald A Fleming, Carolyn J Bowen, et al.
Cancer|January 14, 2009
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanomaAhmad A Tarhini, Michael Millward, Paul Mainwaring, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 4, 2013
Bioavailability, metabolism and disposition of oral pazopanib in patients with advanced cancerYanli Deng, Caroline Sychterz, A Benjamin Suttle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
Phase I dose-finding study of pazopanib in hepatocellular carcinoma: evaluation of early efficacy, pharmacokinetics, and pharmacodynamicsThomas Yau, Pei-Jer Chen, Pierre Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancerMichael J Robertson, John M Kirkwood, Theodore F Logan, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Effect of lapatinib on oral digoxin absorption in patientsKevin M Koch, Deborah A Smith, Jeff Botbyl, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2010
A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II doseKyle D Holen, Chandra P Belani, George Wilding, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2013
A randomized, double-blind, placebo-controlled study to evaluate the effect of repeated oral doses of pazopanib on cardiac conduction in patients with solid tumorsElisabeth I Heath, Jeffrey Infante, Lionel D Lewis, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Oncology Reports|August 5, 2003
Vaccination strategies for lymphomasMohammed M Dar, Larry W Kwak
Nature Reviews. Cancer|January 26, 2007
Targeted anti-mitotic therapies: can we improve on tubulin agents?Jeffrey R Jackson, Denis R Patrick, Mohammed M Dar, et al.
Clinical Colorectal Cancer|May 26, 2011
A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumorsTrevor W Dennie, Ronald A Fleming, Carolyn J Bowen, et al.
Cancer|January 14, 2009
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanomaAhmad A Tarhini, Michael Millward, Paul Mainwaring, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 4, 2013
Bioavailability, metabolism and disposition of oral pazopanib in patients with advanced cancerYanli Deng, Caroline Sychterz, A Benjamin Suttle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
Phase I dose-finding study of pazopanib in hepatocellular carcinoma: evaluation of early efficacy, pharmacokinetics, and pharmacodynamicsThomas Yau, Pei-Jer Chen, Pierre Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancerMichael J Robertson, John M Kirkwood, Theodore F Logan, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Effect of lapatinib on oral digoxin absorption in patientsKevin M Koch, Deborah A Smith, Jeff Botbyl, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2010
A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II doseKyle D Holen, Chandra P Belani, George Wilding, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2013
A randomized, double-blind, placebo-controlled study to evaluate the effect of repeated oral doses of pazopanib on cardiac conduction in patients with solid tumorsElisabeth I Heath, Jeffrey Infante, Lionel D Lewis, et al.
Pageof 2